**Question:** Which of the following inducing agent is preferred for Electroconvulsive Therapy (ECT)?

**Core Concept:** Electroconvulsive therapy is a procedure involving the administration of anesthesia and a seizure-inducing electrical stimulus to the brain to treat severe psychiatric disorders like major depressive disorder, bipolar disorder, and schizophrenia. The choice of anesthesia is crucial for the effectiveness and safety of the procedure.

**Why the Correct Answer is Right:** Midazolam is a short-acting benzodiazepine, which has a rapid onset and short duration of action. It is commonly used as an anesthetic agent for ECT due to its rapid absorption, fast distribution, and quick recovery time. Additionally, it has a minimal effect on cardiac and respiratory functions, making it a safer choice for this procedure.

**Why Each Wrong Option is Incorrect:**

A. Thiopentone: This is a short-acting barbiturate that has a longer duration of action compared to midazolam. Its use for ECT might lead to prolonged respiratory depression and increased risk of complications.

B. Fentanyl: Fentanyl is a potent opioid analgesic used for pain management. Its rapid onset and short duration of action make it unsuitable for ECT, as it may not provide sufficient anesthesia and seizure control.

C. Propofol: While propofol is a widely used anesthetic agent, it has a longer duration of action compared to midazolam. This may result in inadequate seizure control and increased risk of complications during ECT.

D. Thiopentone: As mentioned earlier, thiopentone has a longer duration of action and may lead to prolonged respiratory depression and increased risk of complications during ECT.

**Clinical Pearl:** Midazolam is the preferred anesthetic agent for ECT due to its rapid onset, short duration of action, and minimal impact on respiratory and cardiac functions. This combination ensures adequate anesthesia, seizure control, and minimizes complications during ECT.